Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 15 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Operating Activities      
Net loss $ (164,103) $ (145,928)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Interest earned on cash and marketable securities held in Trust Account (706,074) (47,784)  
Interest receivable on cash and marketable securities held in Trust Account (41,112)    
Change in operating assets and liabilities:      
Receivable from related party 2,166    
Prepaid expenses 17,416 (152,417)  
Accounts payable 1,176,790 3,009  
Accrued liabilities (772,840)    
Other current liabilities (7,326) 83,227  
Net cash used in operating activities (495,083) (259,893)  
Investing Activities      
Restricted cash   (71,640)  
Investment of cash in Trust Account, net   (125,000,000)  
Cash withdrawn from Trust Account 222,115   $ 601,238
Net cash provided by (used in) investing activities 222,115 (125,071,640)  
Financing Activities      
Proceeds from sale of Units, net of underwriting discounts paid   122,500,000  
Proceeds from sale of Private Placement Units   4,895,000  
Proceeds from the sale of Founder Shares   25,000  
Promissory notes from related parties   50,536  
Repayment of promissory notes from related parties   (50,536)  
Payment of deferred offering costs   (380,205)  
Net cash provided by financing activities   127,039,795  
Net change in cash and cash equivalents (272,968) 1,708,262  
Cash and cash equivalents, beginning of period 597,268    
Cash and cash equivalents, end of period 324,300 1,708,262 $ 324,300
Supplemental disclosure of noncash investing activities      
Change in value of common stock subject to possible redemption $ (164,103) $ (389,224)